Joel Neal
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer Metastatic Non-Squamous Non-Small Cell Lung Carcinoma | Phase 2 | 2016-10-01 |
| Completed | Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer Stage IV Non-small Cell Lung Cancer (NSCLC), Recurrent Non-small Cell Lung Cancer (NSCLC), Extensive-stage Small Cell Lung Cancer (SCLC) | Phase 2 | 2015-08-01 |
| Terminated | Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors Small Cell Lung Cancer (SCLC), Neuroendocrine Tumors | Phase 2 | 2012-10-01 |